Cargando…
TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration
Autores principales: | Gao, Rui, Meng, Mei, Zhou, Xianchao, Yu, Miao, Li, Zhifan, Li, Jingquan, Wang, Xiaonan, Song, Yizhi, Wang, Hui, He, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126026/ https://www.ncbi.nlm.nih.gov/pubmed/35620019 http://dx.doi.org/10.1002/mco2.139 |
Ejemplares similares
-
Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
por: He, Jian, et al.
Publicado: (2021) -
Synthetic cytokine circuits that drive T cell infiltration into immune-excluded tumors
por: Allen, Greg M., et al.
Publicado: (2022) -
Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies
por: He, Jian, et al.
Publicado: (2023) -
Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2022) -
CSF1R is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in the Gastric Cancer Microenvironment
por: Chen, Di, et al.
Publicado: (2021)